The store will not work correctly when cookies are disabled.
(-)-calystegine B2
ID: ALA513797
Chembl Id: CHEMBL513797
PubChem CID: 23642747
Max Phase: Preclinical
Molecular Formula: C7H13NO4
Molecular Weight: 175.18
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Synonyms: (-)-Calystegine B2 | (-)-calystegine B2|CHEMBL513797
Canonical SMILES: O[C@H]1[C@H](O)[C@H](O)[C@@]2(O)CC[C@@H]1N2
Standard InChI: InChI=1S/C7H13NO4/c9-4-3-1-2-7(12,8-3)6(11)5(4)10/h3-6,8-12H,1-2H2/t3-,4+,5-,6-,7-/m0/s1
Standard InChI Key: FXFBVZOJVHCEDO-REQIZBSHSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 175.18 | Molecular Weight (Monoisotopic): 175.0845 | AlogP: -2.48 | #Rotatable Bonds: 0 |
Polar Surface Area: 92.95 | Molecular Species: BASE | HBA: 5 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.13 | CX Basic pKa: 8.57 | CX LogP: -2.15 | CX LogD: -3.35 |
Aromatic Rings: 0 | Heavy Atoms: 12 | QED Weighted: 0.28 | Np Likeness Score: 2.80 |
References
1. Goldmann A, Message B, Tepfer D, Molyneux RJ, Duclos O, Boyer FD, Pan YT, Elbein AD.. (1996) Biological activities of the nortropane alkaloid, calystegine B2, and analogs: structure-function relationships., 59 (12): [PMID:8988598] [10.1021/np960409v] |